Successful shunt closure and improvement of hemodynamics in an ASD patient with severe pulmonary arterial hypertension and small shunt following a long-term use of bosentan

被引：8

作者：

Tahara, Nobuhiro ^{[1
]}

Mizoguchi, Minori ^{[1
]}

Honda, Akihiro ^{[1
]}

Tahara, Atsuko ^{[1
]}

Nitta, Yoshikazu ^{[1
]}

Kodama, Norihiro ^{[1
]}

Koiwaya, Hiroshi ^{[1
]}

Aoyagi, Shigeaki ^{[2
]}

Imaizumi, Tsutomu ^{[1
]}

机构：

[1] Kurume Univ, Sch Med, Dept Med, Div Cardiovasc Med, Kurume, Fukuoka 830, Japan

[2] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2012年 / 158卷 / 02期

关键词：

Pulmonary arterial hypertension; Atrial septal defect; Bosentan; SEPTAL-DEFECT CLOSURE; THERAPY; EPOPROSTENOL;

D O I：

10.1016/j.ijcard.2011.10.027

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E38 / E40

页数：3

共 50 条

[41] LONG-TERM OUTCOME WITH FIRST-LINE BOSENTAN THERAPY IN SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
Launay, D.
Sitbon, O.
Le Pavec, J.
Savale, L.
Tcherakian, C.
Yaici, A.
Achouh, L.
Parent, F.
Jais, X.
Simonneau, G.
Humbert, M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S159 - S159
[42] Long-Term Outcomes in Children With Pulmonary Arterial Hypertension Treated With Bosentan in Real-World Clinical Settings
Ivy, D. Dunbar
Rosenzweig, Erika Berman
Lemarie, Jean-Christophe
Brand, Monika
Rosenberg, Daniel
Barst, Robyn J.
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (09): : 1332 - 1338
[43] Long-Term Treatment of Pulmonary Arterial Hypertension with Treprostinil in Patient with Eisenmenger and Down Syndromes
Gasior, Z.
Sikora-Puz, A.
Banska-Kisiel, K.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[44] Long-term safety profile of bosentan in patients with systemic sclerosis and pulmonary arterial hypertension: Results from the TRAX database
Denton, CP
Coghlan, J
Black, CM
Hoeper, MM
Kiely, DG
Carlsen, J
Van Lierop, C
Humbert, M
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 294 - 294
[45] Long-term outcomes in pulmonary arterial hypertension in the first-line epoprostenol or first-line bosentan era
Jacobs, Wouter
Boonstra, Anco
Brand, Monika
Rosenberg, Daniel M.
Schaaf, Berthold
Postmus, Pieter E.
Noordegraaf, Anton Vonk
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (10): : 1150 - 1158
[46] Long-term outcome with first-line bosentan therapy in systemic sclerosis-associated pulmonary arterial hypertension
Launay, David
Sitbon, Olivier
Jais, Xavier
Yaici, Azzedine
Le Pavec, Jerome
Tcherakian, Colas
Humbert, Marc
Simonneau, Gerald
ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S819 - S819
[47] EFFICACY AND SAFETY OF LONG-TERM PAH-SPECIFIC MONO-THERAPY WITH BOSENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
Paramonov, V.
Martynyuk, T.
Chazova, I. E.
JOURNAL OF HYPERTENSION, 2015, 33 : E195 - E195
[48] Bosentan first-line treatment in pulmonary arterial hypertension: long-term clinical outcome and echocardiographic and Doppler measures
Loban, C. Fernandez-Gofin
Escribano, P.
Tello, R.
Gutierrez, H.
Sanchez, M. A. Gomez
Delgado, J.
Jimenez, C.
de la Calzada, C. Saenz
EUROPEAN HEART JOURNAL, 2005, 26 : 77 - 77
[49] Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients
Simonneau, Gerald
Galie, Nazzareno
Jansa, Pavel
Bohns Meyer, Gisela Martina
Al-Hiti, Hikmet
Kusic-Pajic, Andjela
Lemarie, Jean-Christophe
Hoeper, Marius M.
Rubin, Lewis J.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (02) : 332 - 339
[50] Inadvertent irreversible closure of arterial duct following therapeutic use of transplacental indomethacin in a fetus with severe Ebstein's anomaly and circular shunt
Gill, K.
Arbic, N.
Seed, M.
Honjo, O.
Ryan, G.
Jaeggi, E.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2021, 58 (06) : 940 - 942

← 1 2 3 4 5 →